指南与共识泌尿生殖与妇科肿瘤放疗放疗物理与技术

基于轮廓的改良德尔菲共识:定义前列腺内大体肿瘤体积与微推量

Defining Intraprostatic Gross Tumor Volume and Microboosting through Consensus: A Contour-Based Modified Delphi Consensus.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2026-07-29

国际放射肿瘤专家参与轮廓勾画练习与两轮改良德尔菲共识,评估前列腺癌大体肿瘤体积(GTV)勾画一致性并形成微推量指导。简单病例勾画一致性高,复杂病例明显降低;131条陈述中43条达成共识或强共识。

要点

  • 多参数MRI联合PSMA PET可辅助前列腺内GTV勾画与微推量。
  • 简单病例勾画一致性高,影像不一致的复杂病例一致性明显降低。
  • 基于PSMA PET的GTV始终大于基于多参数MRI的GTV。

核心结论

  • 复杂病例的GTV勾画存在变异性,专家共识可为前列腺GTV微推量的标准化实施提供参考。

研究设计与样本

  • 参与者在2例前列腺癌病例的多参数MRI和PSMA PET图像上勾画GTV,其中1例为影像不一致的复杂病例。

主要发现

  • 简单病例勾画一致性高,复杂病例一致性显著降低。
  • 基于PSMA PET的GTV始终大于基于多参数MRI的GTV。
  • 131条陈述中43条(33%)达成共识或强共识。

关键数值与推荐

  • 共识和强共识分别预设为≥75%和≥90%的一致性。
  • 达成共识:多参数MRI使用T2WI联合DWI/ADC序列勾画GTV。
  • 达成共识:PI-RADS 4至5和PROMISE 4至5病灶适合推量。
  • 达成共识:优先使用PSMA靶向示踪剂,联合PET与MRI信息时避免临床靶区外放。
  • 未达成共识:临床试验外的SBRT微推量、单模态影像外放边界、GTV或未受累前列腺的最佳处方剂量。

临床怎么用

  • 可参考专家共识选择适合微推量的病灶并规范多参数MRI与PSMA PET联合勾画流程。
  • 对影像不一致的复杂病例需警惕勾画变异性,临床试验外SBRT微推量及单模态影像外放尚无共识。

局限性

  • 复杂病例勾画一致性低,部分关键临床问题未达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Advances in imaging have enabled identification of intraprostatic gross tumor volumes (GTVs), creating opportunities for microboosting in prostate radiation therapy. However, variability exists in patient selection, target delineation, and treatment planning. This study aimed to characterize expert contouring variability and establish consensus guidance for GTV microboosting using a contour-based modified Delphi consensus. METHODS AND MATERIALS: International radiation oncologists with expertise in GTV microboosting participated in a 2-part study comprising a contouring exercise and a 2-round modified Delphi consensus. Participants contoured GTVs in 2 prostate cancer cases with multiparametric magnetic resonance imaging (MRI) and prostate-specific membrane antigen positron emission tomography imaging, including 1 complex case with imaging discordance. Contouring agreement was assessed using Fleiss κ, intraclass correlation coefficients, and simultaneous truth and performance level estimation analysis. Participants subsequently completed iterative Delphi surveys addressing patient selection, imaging requirements, contouring practices, and treatment planning. Consensus and strong consensus were predefined as ≥75% and ≥90% agreement, respectively. RESULTS: Fifteen of 20 invited experts completed the study. Contouring agreement was high in the simpler case but substantially lower in the complex case. Prostate-specific membrane antigen positron emission tomography-based GTVs were consistently larger than multiparametric MRI-based GTVs. Overall, consensus or strong consensus was achieved for 43 of 131 statements (33%). Agreement was reached on key aspects of GTV delineation, including the use of combined T2-weighted and diffusion weighted images/Apparent Diffusion Coefficient sequences on multiparametric MRI, eligibility of Prostate Imaging Reporting and Data System 4 to 5 and PROMISE (Prostate Cancer Molecular Imaging Standardize Evaluation) 4 to 5 lesions for boosting, preferred use of prostate-specific membrane antigen-targeted tracers, and avoidance of clinical target volume margins when positron emission tomography and MRI information are used in combination. No consensus was achieved on stereotactic body radiation therapy microboosting outside clinical trials, margin expansion using single-modality imaging, or optimal dose prescriptions to the GTV or uninvolved prostate. CONCLUSION: This contour-based modified Delphi study demonstrates variability in GTV delineation for complex cases and identifies areas of expert consensus that can inform standardized implementation of prostate GTV microboosting.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Mendez LC, Zamboglou C, Al-Uwini S, et al. Defining Intraprostatic Gross Tumor Volume and Microboosting through Consensus: A Contour-Based Modified Delphi Consensus. Int J Radiat Oncol Biol Phys. 2026. PMID: 42526651. doi:10.1016/j.ijrobp.2026.07.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。